What is Particle3D?
Particle3D, operating under the brand Ossiform, specializes in the development of bioactive bone substitutes that facilitate natural bone regeneration. The company utilizes cutting-edge 3D printing processes to manufacture fully resorbable materials that provide essential structural support for patients suffering from complex bone defects. By addressing the limitations of traditional bone grafts—such as donor site morbidity and implant rejection—the company offers a sophisticated alternative for surgeons and healthcare providers.
The firm's market position is defined by its commitment to clinical efficacy and material science innovation. By integrating seamlessly into existing surgical workflows, Particle3D is redefining the standard of care for bone replacement, moving away from static, off-the-shelf solutions toward dynamic, bio-compatible implants that promote healing at the cellular level.
How much funding has Particle3D raised?
Particle3D has raised a total of $3.1M across 1 funding round:
Other Financing Round
$3.1M
Other Financing Round (2020): $3.1M with participation from West Hill Capital LLP
Key Investors in Particle3D
West Hill Capital LLP
A specialized investment firm focused on providing growth capital and strategic advisory services to high-potential companies in the healthcare and technology sectors.
What's next for Particle3D?
With the recent influx of capital, Particle3D is well-positioned to accelerate its clinical validation programs and expand its manufacturing capacity. The strategic roadmap likely includes deepening its footprint in international markets and securing additional regulatory clearances for its suite of 3D-printed implants. As the company scales, the focus will remain on optimizing the material properties of its resorbable scaffolds to ensure superior integration with host tissue.
Furthermore, the company is expected to leverage this financing to foster collaborative research initiatives with leading orthopedic institutions. By establishing a robust evidence base, Particle3D aims to solidify its role as a primary provider of regenerative solutions, ultimately reducing the complication rates associated with traditional bone reconstruction and improving long-term patient outcomes in the orthopedic and maxillofacial surgery sectors.
